Literature DB >> 19708127

A novel point mutation in the CYBB gene promoter leading to a rare X minus chronic granulomatous disease variant--impact on the microbicidal activity of neutrophils.

Federica Defendi1, Eva Decleva, Cécile Martel, Pietro Dri, Marie José Stasia.   

Abstract

This article reports an atypical and extremely rare case of X-linked CGD in an Italian family characterized by a low expression of gp91phox (X91- CGD). A novel point mutation in the CYBB gene's promoter (insertion of a T at position -54T to -56T) appeared to prevent the full expression of this gene in the patient's neutrophils and correlated with a residual oxidase activity in the whole cells population. The expression and functional activity of the oxidase in eosinophils appeared to be almost normal. Gel shift assays indicated that the mutation led to decreased interactions with DNA-binding proteins. The total O2- production in the patient's granulocytes (5-7% of normal) supported no microbicidal power after 45 min and 60 min of contact with S. aureus and C. albicans, respectively. Despite this residual oxidase activity, the patients suffered from severe and life-threatening infections. It was concluded that in these X91- CGD neutrophils, the O2- production per se was not sufficient to protect the patient against severe infections.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19708127     DOI: 10.1016/j.bbadis.2009.01.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

Review 1.  Adult-onset presentations of genetic immunodeficiencies: genes can throw slow curves.

Authors:  Katharine S Nelson; David B Lewis
Journal:  Curr Opin Infect Dis       Date:  2010-08       Impact factor: 4.915

Review 2.  Hematologically important mutations: X-linked chronic granulomatous disease (third update).

Authors:  Dirk Roos; Douglas B Kuhns; Anne Maddalena; Joachim Roesler; Juan Alvaro Lopez; Tadashi Ariga; Tadej Avcin; Martin de Boer; Jacinta Bustamante; Antonio Condino-Neto; Gigliola Di Matteo; Jianxin He; Harry R Hill; Steven M Holland; Caroline Kannengiesser; M Yavuz Köker; Irina Kondratenko; Karin van Leeuwen; Harry L Malech; László Marodi; Hiroyuki Nunoi; Marie-José Stasia; Anna Maria Ventura; Carl T Witwer; Baruch Wolach; John I Gallin
Journal:  Blood Cells Mol Dis       Date:  2010-08-21       Impact factor: 3.039

3.  Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cells.

Authors:  Giorgia Santilli; Elena Almarza; Christian Brendel; Uimook Choi; Chiara Beilin; Michael P Blundell; Sneha Haria; Kathryn L Parsley; Christine Kinnon; Harry L Malech; Juan A Bueren; Manuel Grez; Adrian J Thrasher
Journal:  Mol Ther       Date:  2010-10-26       Impact factor: 11.454

4.  Variant Type X91+ Chronic Granulomatous Disease: Clinical and Molecular Characterization in a Chinese Cohort.

Authors:  Bijun Sun; Zeyu Zhu; Xiaoying Hui; Jinqiao Sun; Wenjie Wang; Wenjing Ying; Qinhua Zhou; Haili Yao; Jia Hou; Xiaochuan Wang
Journal:  J Clin Immunol       Date:  2022-07-07       Impact factor: 8.317

Review 5.  Mutation analysis in primary immunodeficiency diseases: case studies.

Authors:  Amy P Hsu; Thomas A Fleisher; Julie E Niemela
Journal:  Curr Opin Allergy Clin Immunol       Date:  2009-12

6.  Late diagnosis and advances in genetics of chronic granulomatous disease.

Authors:  G Di Matteo; A Finocchi
Journal:  Clin Exp Immunol       Date:  2020-12-13       Impact factor: 4.330

7.  Chronic granulomatous disease presenting as aseptic ascites in a 2-year-old child.

Authors:  J F Moreau; John A Ozolek; P Ling Lin; Todd D Green; Elaine A Cassidy; Veena L Venkat; Andrew R Buchert
Journal:  Case Reports Immunol       Date:  2013-01-28

8.  Optimized Generation of Functional Neutrophils and Macrophages from Patient-Specific Induced Pluripotent Stem Cells: Ex Vivo Models of X(0)-Linked, AR22(0)- and AR47(0)- Chronic Granulomatous Diseases.

Authors:  Julie Brault; Erwan Goutagny; Narasimha Telugu; Kaifeng Shao; Mathurin Baquié; Véronique Satre; Charles Coutton; Didier Grunwald; Jean-Paul Brion; Vincent Barlogis; Jean-Louis Stephan; Dominique Plantaz; Jürgen Hescheler; Karl-Heinz Krause; Tomo Sarić; Marie José Stasia
Journal:  Biores Open Access       Date:  2014-12-01

9.  Clinical, functional and genetic characterization of 16 patients suffering from chronic granulomatous disease variants - identification of 11 novel mutations in CYBB.

Authors:  M Mollin; S Beaumel; B Vigne; J Brault; N Roux-Buisson; J Rendu; V Barlogis; G Catho; C Dumeril; F Fouyssac; D Monnier; V Gandemer; M Revest; J-P Brion; C Bost-Bru; E Jeziorski; L Eitenschenck; C Jarrasse; S Drillon Haus; M Houachée-Chardin; M Hancart; G Michel; Y Bertrand; D Plantaz; J Kelecic; R Traberg; L Kainulainen; J Fauré; F Fieschi; M J Stasia
Journal:  Clin Exp Immunol       Date:  2020-10-12       Impact factor: 4.330

10.  Residual NADPH oxidase activity and isolated lung involvement in x-linked chronic granulomatous disease.

Authors:  Maria J Gutierrez; George D McSherry; Faoud T Ishmael; Alexandra A Horwitz; Gustavo Nino
Journal:  Case Rep Pediatr       Date:  2012-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.